Cwm LLC Reduces Position in Amdocs Limited $DOX

Cwm LLC lessened its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 6.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 106,657 shares of the technology company’s stock after selling 7,598 shares during the quarter. Cwm LLC owned approximately 0.10% of Amdocs worth $8,587,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also modified their holdings of the business. Pzena Investment Management LLC boosted its stake in shares of Amdocs by 0.6% during the 3rd quarter. Pzena Investment Management LLC now owns 6,593,249 shares of the technology company’s stock worth $540,976,000 after acquiring an additional 42,184 shares during the last quarter. LSV Asset Management boosted its stake in shares of Amdocs by 7.6% during the 3rd quarter. LSV Asset Management now owns 3,648,703 shares of the technology company’s stock worth $299,376,000 after acquiring an additional 257,193 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in shares of Amdocs by 1.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock worth $253,786,000 after acquiring an additional 54,676 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Amdocs by 3.0% during the 3rd quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock worth $258,583,000 after acquiring an additional 91,900 shares during the last quarter. Finally, Vanguard Group Inc. boosted its stake in shares of Amdocs by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company’s stock worth $251,602,000 after acquiring an additional 9,207 shares during the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Stock Performance

Shares of NASDAQ DOX opened at $67.63 on Monday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06. The company has a market cap of $7.30 billion, a P/E ratio of 13.08, a P/E/G ratio of 1.20 and a beta of 0.46. The firm’s fifty day moving average is $67.17 and its two-hundred day moving average is $75.85. Amdocs Limited has a 52-week low of $62.75 and a 52-week high of $95.41.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.75 by $0.06. The company had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.15 billion. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. Amdocs’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.66 EPS. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, analysts anticipate that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be issued a $0.569 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $2.28 dividend on an annualized basis and a yield of 3.4%. This is an increase from Amdocs’s previous quarterly dividend of $0.53. Amdocs’s payout ratio is presently 44.10%.

Analyst Ratings Changes

Several brokerages have recently weighed in on DOX. Stifel Nicolaus dropped their price target on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research note on Tuesday, January 27th. Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Barclays lowered their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 4th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Amdocs currently has an average rating of “Moderate Buy” and a consensus target price of $92.33.

Amdocs Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.